Cargando…

Cost of Living with Parkinson's Disease over 12 Months in Australia: A Prospective Cohort Study

Background. Parkinson disease (PD) is a costly chronic condition in terms of managing both motor and nonmotor symptoms. The burden of disease is high for individuals, caregivers, and the health system. The aim of this study is to estimate the annual cost of PD from the household, health system, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bohingamu Mudiyanselage, Shalika, Watts, Jennifer J., Abimanyi-Ochom, Julie, Lane, Lisa, Murphy, Anna T., Morris, Meg E., Iansek, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352887/
https://www.ncbi.nlm.nih.gov/pubmed/28352490
http://dx.doi.org/10.1155/2017/5932675
_version_ 1782515046883000320
author Bohingamu Mudiyanselage, Shalika
Watts, Jennifer J.
Abimanyi-Ochom, Julie
Lane, Lisa
Murphy, Anna T.
Morris, Meg E.
Iansek, Robert
author_facet Bohingamu Mudiyanselage, Shalika
Watts, Jennifer J.
Abimanyi-Ochom, Julie
Lane, Lisa
Murphy, Anna T.
Morris, Meg E.
Iansek, Robert
author_sort Bohingamu Mudiyanselage, Shalika
collection PubMed
description Background. Parkinson disease (PD) is a costly chronic condition in terms of managing both motor and nonmotor symptoms. The burden of disease is high for individuals, caregivers, and the health system. The aim of this study is to estimate the annual cost of PD from the household, health system, and societal perspectives. Methods. A prospective cohort study of newly referred people with PD to a specialist PD clinic in Melbourne, Australia. Participants completed baseline and monthly health resource use questionnaires and Medicare data were collected over 12 months. Results. 87 patients completed the 12-month follow-up assessments. The mean annual cost per person to the health care system was $32,556 AUD. The burden to society was an additional $45,000 per annum per person with PD. The largest component of health system costs were for hospitalisation (69% of total costs). The costs for people with moderate to severe disease were almost 4 times those with mild PD ($63,569 versus $17,537 p < 0.001). Conclusion. PD is associated with significant costs to individuals and to society. Costs escalated with disease severity suggesting that the burden to society is likely to grow with the increasing disease prevalence that is associated with population ageing.
format Online
Article
Text
id pubmed-5352887
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-53528872017-03-28 Cost of Living with Parkinson's Disease over 12 Months in Australia: A Prospective Cohort Study Bohingamu Mudiyanselage, Shalika Watts, Jennifer J. Abimanyi-Ochom, Julie Lane, Lisa Murphy, Anna T. Morris, Meg E. Iansek, Robert Parkinsons Dis Research Article Background. Parkinson disease (PD) is a costly chronic condition in terms of managing both motor and nonmotor symptoms. The burden of disease is high for individuals, caregivers, and the health system. The aim of this study is to estimate the annual cost of PD from the household, health system, and societal perspectives. Methods. A prospective cohort study of newly referred people with PD to a specialist PD clinic in Melbourne, Australia. Participants completed baseline and monthly health resource use questionnaires and Medicare data were collected over 12 months. Results. 87 patients completed the 12-month follow-up assessments. The mean annual cost per person to the health care system was $32,556 AUD. The burden to society was an additional $45,000 per annum per person with PD. The largest component of health system costs were for hospitalisation (69% of total costs). The costs for people with moderate to severe disease were almost 4 times those with mild PD ($63,569 versus $17,537 p < 0.001). Conclusion. PD is associated with significant costs to individuals and to society. Costs escalated with disease severity suggesting that the burden to society is likely to grow with the increasing disease prevalence that is associated with population ageing. Hindawi 2017 2017-03-02 /pmc/articles/PMC5352887/ /pubmed/28352490 http://dx.doi.org/10.1155/2017/5932675 Text en Copyright © 2017 Shalika Bohingamu Mudiyanselage et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bohingamu Mudiyanselage, Shalika
Watts, Jennifer J.
Abimanyi-Ochom, Julie
Lane, Lisa
Murphy, Anna T.
Morris, Meg E.
Iansek, Robert
Cost of Living with Parkinson's Disease over 12 Months in Australia: A Prospective Cohort Study
title Cost of Living with Parkinson's Disease over 12 Months in Australia: A Prospective Cohort Study
title_full Cost of Living with Parkinson's Disease over 12 Months in Australia: A Prospective Cohort Study
title_fullStr Cost of Living with Parkinson's Disease over 12 Months in Australia: A Prospective Cohort Study
title_full_unstemmed Cost of Living with Parkinson's Disease over 12 Months in Australia: A Prospective Cohort Study
title_short Cost of Living with Parkinson's Disease over 12 Months in Australia: A Prospective Cohort Study
title_sort cost of living with parkinson's disease over 12 months in australia: a prospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352887/
https://www.ncbi.nlm.nih.gov/pubmed/28352490
http://dx.doi.org/10.1155/2017/5932675
work_keys_str_mv AT bohingamumudiyanselageshalika costoflivingwithparkinsonsdiseaseover12monthsinaustraliaaprospectivecohortstudy
AT wattsjenniferj costoflivingwithparkinsonsdiseaseover12monthsinaustraliaaprospectivecohortstudy
AT abimanyiochomjulie costoflivingwithparkinsonsdiseaseover12monthsinaustraliaaprospectivecohortstudy
AT lanelisa costoflivingwithparkinsonsdiseaseover12monthsinaustraliaaprospectivecohortstudy
AT murphyannat costoflivingwithparkinsonsdiseaseover12monthsinaustraliaaprospectivecohortstudy
AT morrismege costoflivingwithparkinsonsdiseaseover12monthsinaustraliaaprospectivecohortstudy
AT iansekrobert costoflivingwithparkinsonsdiseaseover12monthsinaustraliaaprospectivecohortstudy